ZYNTEGLO Trademark

Trademark Overview

On Wednesday, January 30, 2019, a trademark application was filed for ZYNTEGLO with the United States Patent and Trademark Office. The USPTO has given the ZYNTEGLO trademark a serial number of 79254523. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Friday, November 21, 2025. This trademark is owned by bluebird bio (UK) Ltd.. The ZYNTEGLO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical research and development

Pharmaceutical preparations and substances for the treatment of genetic diseases
zynteglo

General Information

Serial Number79254523
Word MarkZYNTEGLO
Filing DateWednesday, January 30, 2019
Status706 - SECTION 71 ACCEPTED
Status DateFriday, November 21, 2025
Registration Number5887775
Registration DateTuesday, October 22, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements

Goods and ServicesPharmaceutical research and development
Goods and ServicesPharmaceutical preparations and substances for the treatment of genetic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 25, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenetix Biotherapeutics, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressUS
Party Namebluebird bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02145
Party Namebluebird bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party Namebluebird bio, Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party Namebluebird bio (UK) Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, March 21, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 29, 2019APPLICATION FILING RECEIPT MAILED
Wednesday, April 10, 2019ASSIGNED TO EXAMINER
Friday, April 12, 2019NON-FINAL ACTION WRITTEN
Saturday, April 13, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 6, 2019REFUSAL PROCESSED BY MPU
Monday, May 6, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 16, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 16, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 25, 2019REFUSAL PROCESSED BY IB
Friday, June 7, 2019ASSIGNED TO LIE
Thursday, June 13, 2019CHANGE OF OWNER RECEIVED FROM IB
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, August 30, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, September 13, 2019ELECTRONIC RECORD REVIEW COMPLETE
Friday, October 18, 2019NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 22, 2019REGISTERED-PRINCIPAL REGISTER
Friday, November 15, 2019NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, January 22, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, February 10, 2020FINAL DISPOSITION PROCESSED
Monday, February 10, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 28, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 26, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, December 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, June 15, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 13, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 22, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, July 22, 2025TEAS SECTION 71 RECEIVED
Friday, November 14, 2025NEW REPRESENTATIVE AT IB RECEIVED
Monday, November 17, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 21, 2025REGISTERED-SEC.71 ACCEPTED
Friday, November 21, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, December 18, 2025CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

zynteglo pharmaceutical genetic diseases treatment preparations research development substances